Ah receptor, CYP1A1, CYP1A2 AND CYP1B1 gene polymorphisms are not involved in the risk of recurrent pregnancy loss

Molecular Human Reproduction

Volumn 10, Issue 10, 2004, Pages 729-733

  Saijo, Y ^a   Sata, F ^a   Yamada, H ^a   Suzuki, K ^a   Sasaki, S ^a   Kondo, T ^a   Gong, Y Y ^a   Kato, E H ^a   Shimada, S ^a   Morikawa, M ^a   Minakami, H ^a   Kishi, R ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Ah receptor; CYP1A1; CYP1A2; CYP1B1; Recurrent pregnancy loss

Indexed keywords

ADENINE; ARGININE; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; CYTOSINE; LEUCINE; LYSINE; VALINE;

ADULT; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC REGULATION; GENOTYPE; HUMAN; HUMAN CELL; JAPAN; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT ABORTION; RISK ASSESSMENT;

ABORTION, HABITUAL; ADULT; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; MIDDLE AGED; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY OUTCOME; RECEPTORS, ARYL HYDROCARBON; RISK FACTORS;

EID: 5044250022     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/gah096     Document Type: Article

References (54)

1. Aldrich CL, Stephenson MD, Karrison T, Odem RR, Branch DW, Scott JR, Schreiber JR and Ober C (2001) HLA-G genotypes and pregnancy outcome in couples with unexplained recurrent miscarriage. Mol Hum Reprod 7,1167-1172.
2. Allen J, Barsotti D, Lambrecht L and Van Miller J (1979) Reproductive effects of halogenated aromatic hydrocarbons on nonhuman primates. Ann NY Acad Sci 320,419-425.
3. Baranova H, Canis M, Ivaschenko T, Albuisson E, Bothorishvilli R, Baranov V, Malet P and Bruhat MA (1999) Possible involvement of arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 genes in the development of endometriosis. Mol Hum Reprod 5,636-641.
4. Bjerke D, Sommer R, Moore R and Peterson R (1994) Effects of in utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposures on responsiveness of the male rat reproductive system to testosterone stimulation in adulthood. Toxicol Appl Pharmacol 127,250-257.
5. Browner WS, Newman TB, Cummings SR and Hulley SB (2001) Estimating sample size and power: the nitty-gritty. In: Hulley SB, Cummings SR, Browner WS, Grady D, Hearst N, and Newman TB (eds), Designing Clinical Research. Lippincott Williams & Wilkins, Philadelphia, PA, pp. 65-91.
6. Chida M, Yokoi T, Fukui T, Kinoshita M, Yokota J and Kamataki T (1999) Detection of three genetic polymorphisms in the 5′ -flanking region and intron 1 of human CYP1A2 in the Japanese population. Jpn J Cancer Res 90,899-902.
7. Christiansen L, Bygum A, Jensen A, Thomsen K, Brandrup F, Horder M and Petersen NE (2000) Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda. Hum Genet 107,612-614.
8. Courtney KD (1976) Mouse teratology studies with chlorodibenzo-p-dioxins. Bull Environ Contam Toxicol 16,674-681.
9. Cramer DW and Wise LA (2000) The epidemiology of recurrent pregnancy loss. Semin Reprod Med 18,331-339.
10. de Kok JB, Wiegerinck ET, Giesendorf BA and Swinkels DW (2002) Rapid genotyping of single nucleotide polymorphisms using novel minor groove binding DNA oligonucleotides (MGB probes). Hum Mutat 19,554-559.
11. Dossenbach-Glaninger A, van Trotsenburg M, Dossenbach M, Oberkanins C, Moritz A, Krugluger W, Huber J and Hopmeier P (2003) Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss. Clin Chem 49,1081-1086.
12. Eaton DL, Gallagher EP, Bammler TK and Kunze KL (1995) Role of cytochrome P4501A2 in chemical carcinogenesis: implications for human variability in expression and enzyme activity. Pharmacogenetics 5,259-274.
13. Eskenazi B, Mocarelli P, Warner M, Chee WY, Gerthoux PM, Samuels S, Needham LL and Patterson DG Jr (2003) Maternal serum dioxin levels and birth outcomes in women of Seveso, Italy. Environ Health Perspect 111,947-953.
14. Fenster L, Eskenazi B, Windham GC and Swan SH (1991) Caffeine consumption during pregnancy and spontaneous abortion. Epidemiology 2, 168-174.
15. Gardella JR and Hill JA III (2000) Environmental toxins associated with recurrent pregnancy loss. Semin Reprod Med 18,407-424.
16. Hanna IH, Dawling S, Roodi N, Guengerich FP and Parl FF (2000) Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res 60,3440-3444.
17. Karhukorpi J, Laitinen T, Kivela H, Tiilikainen A and Hurme M (2003) IL-1 receptor antagonist gene polymorphism in recurrent spontaneous abortion. J Reprod Immunol 58,61-67.
18. Kawajiri K, Watanabe J, Eguchi H, Nakachi K, Kiyohara C and Hayashi S (1995) Polymorphisms of human Ah receptor gene are not involved in lung cancer. Pharmacogenetics 5,151-158.
19. Kiyohara C, Wakai K, Mikami H, Sido K, Ando M and Ohno Y (2003) Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of environmental tobacco smoke and lung cancer: a case-control study in Japanese nonsmoking women. Int J Cancer 107,139-144.
20. Klebanoff MA, Levine RJ, DerSimonian R, Clemens JD and Wilkins DG (1999) Maternal serum paraxanthine, a caffeine metabolite, and the risk of spontaneous abortion. N Engl J Med 341,1639-1644.
21. Landi MT, Bertazzi PA, Shields PG, Clark G, Lucier GW, Garte SJ, Cosma G and Caporaso NE (1994) Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics 4,242-246.
22. Larsen MC, Angus WG, Brake PB, Eltom SE, Sukow KA and Jefcoate CR (1998) Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism. Cancer Res 58, 2366-2374.
23. Li W, Harper PA, Tang BK and Okey AB (1998) Regulation of cytochrome P450 enzymes by aryl hydrocarbon receptor in human cells: CYP1A2 expression in the LS180 colon carcinoma cell line after treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 3-methylcholanthrene. Biochem Pharmacol 56,599-612.
24. Luch A, Coffing SL, Tang YM et al. (1998) Stable expression of human cytochrome P450 1B1 in V79 Chinese hamster cells and metabolically catalyzed DNA adduct formation of dibenzo[a,1]pyrene. Chem Res Toxicol 11,686-695.
25. McNulty W (1984) Fetocidal and teratogenic actions of TCDD. In: Lowrance WW (ed.) Public Health Risks of the Dioxins. Proceedings of the Public Health Risks of the Dioxins symposium, 19-20 October 1983, The Rockefeller University, New York City Willam Kaufman, Inc., Los Altos, CA, pp. 245-253.
26. Murray FJ, Smith FA, Nitschke KD, Humiston CG, Kociba RJ and Schwetz BA (1979) Three-generation reproduction study of rats given 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the diet. Toxicol Appl Pharmacol 50, 241-252.
27. Nau H, Bass R and Neubert D (1986) Transfer of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) via placenta and milk, and postnatal toxicity in the mouse. Arch Toxicol 59,36-40.
28. Nebert DW and Gonzalez FJ (1987) P450 genes: structure, evolution and regulation. Annu Rev Biochem 56,945-993.
29. Parazzini F, Bocciolone L, Fedele L, Negri E, La Vecchia C and Acaia B (1991) Risk factors for spontaneous abortion. Int J Epidemiol 20,157-161.
30. Pfeiffer KA, Fimmers R, Engels G, van der Ven H and van der Ven K (2001) The HLA-G genotype is potentially associated with idiopathic recurrent spontaneous abortion. Mol Hum Reprod 7,373-378.
31. Rey E, Kahn SR, David M and Shrier I (2003) Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 361,901-908.
32. Sachse C, Brockmoller J, Bauer S and Roots I (1999) Functional significance of a C → A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 47,445-449.
33. Safe SH (1995) Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmac Ther 67,247-281.
34. Saijo Y, Sata F, Yamada H, Kondo T, Kato EH and Kishi R (2004) Single nucleotide polymorphisms in the promoter region of the interleukin-6 gene and the risk of recurrent pregnancy loss in Japanese women. Fertil Steril 81,374-378.
35. Sasaki M, Tanaka Y, Kaneuchi M, Sakuragi N and Dahiya R (2003) CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor alpha and estrogen receptor beta expressions. Cancer Res 63,3913-3918.
36. Sata F, Yamada H, Kondo T, Gong Y, Tozaki S, Kobashi G, Kato EH, Fujimoto S and Kishi R (2003a) Glutathione S-transferase M1 and T1 polymorphisms and the risk of recurrent pregnancy loss. Mol Hum Reprod 9,165-169.
37. Sata F, Yamada H, Yamada A et al. (2003b) A polymorphism in the CYP17 gene relates to the risk of recurrent pregnancy loss. Mol Hum Reprod 9, 725-728.
38. Signorello LB, Nordmark A, Granath F et al. (2001) Caffeine metabolism and the risk of spontaneous abortion of normal karyotype fetuses. Obstet Gynecol 98,1059-1066.
39. Smart J and Daly AK (2000) Variation in induced CYP1A1 levels: relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms. Pharmacogenetics 10,11-24.
40. Stirrat GM (1990) Recurrent abortion. II. Clinical associations, causes, and management. Lancet 336,728-733.
41. Tang YM, Wo YY, Stewart J, Hawkins AL, Griffin CA, Sutter TR and Greenlee WF (1996) Isolation and characterization of the human cytochrome P450 CYP1B1 gene. J Biol Chem 271,28324-28330.
42. Tempfer C, Unfried G, Zeillinger R, Hefler L, Nagele F and Huber JC (2001) Endothelial nitric oxide synthase gene polymorphism in women with idiopathic recurrent miscarriage. Hum Reprod 16,644-647.
43. Tsuchiya Y, Nakai S, Nakamura K, Hayashi K, Nakanishi J and Yamamoto M (2003) Effects of dietary habits and CYP1A1 polymorphisms on blood dioxin concentrations in Japanese men. Chemosphere 52,213-219.
44. Turesky RJ, Constable A, Richoz J, Varga N, Markovic J, Martin MV and Guengerich FP (1998) Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2. Chem Res Toxicol 11,925-936.
45. Umbreit T, Hesse E and Gallo M (1987) Reproductive toxicity in female mice of dioxin-contaminated soils from a 2,4,5-trichlorophenoxyacetic acid manufacturing site. Arch Environ Contam Toxicol 16,461-466.
46. Unfried G, Tempfer C, Schneeberger C, Widmar B, Nagele F and Huber JC (2001) Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage. Fertil Steril 75,683-687.
47. Wang X, Zuckerman B, Pearson C et al. (2002) Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 287, 241-242.
48. Wang ZC, Yunis EJ, De los Santos MJ, Xiao L, Anderson DJ and Hill JA (2002) T helper 1-type immunity to trophoblast antigens in women with a history of recurrent pregnancy loss is associated with polymorphism of the IL1B promoter region. Genes Immun 3,38-42.
49. Watanabe T, Imoto I, Kosugi Y et al. (2001) Human arylhydrocarbon receptor repressor (AHRR) gene: genomic structure and analysis of polymorphism in endometriosis. J Hum Genet 46,342-346.
50. Williams JA and Phillips DH (2000) Mammary expression of xenobiotic metabolizing enzymes and their potential role in breast cancer. Cancer Res 60,4667-4677.
51. Wu MT, Ho CK, Huang SL, Yeh YF, Liu CL, Mao IF and Christiani DC (1999) Modulating influence of cytochrome P-450 MspI polymorphism on serum liver function profiles in coke oven workers. Occup Environ Med 56,159-163.
52. Yamada H, Kato EH, Kobashi G, Ebina Y, Shimada S, Morikawa M, Yamada T, Sakuragi S and Fujimoto S (2001) Recurrent pregnancy loss: etiology of thrombophilia. Semin Thromb Hemost 27,121-129.
53. Yamada H, Sata F, Kato EH et al. (2004) A polymorphism in the CYP17 gene and intrauterine fetal growth restriction. Mol Hum Reprod 10,49-53.
54. Yamada H, Sata F, Saijo Y, Kishi R and Minakami H (2004) Genetic factors of fetal growth restriction and miscarriage. Semin Thromb Hemost (in press).